NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis $23.72 -0.41 (-1.70%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$23.56▼$24.2450-Day Range$19.22▼$24.2252-Week Range$17.24▼$24.77Volume125,907 shsAverage Volume241,548 shsMarket Capitalization$1.09 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Avanos Medical alerts: Email Address Avanos Medical MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.63% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.87Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth30.94%From $1.39 to $1.82 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.23 out of 5 starsMedical Sector484th out of 910 stocksSurgical Appliances & Supplies Industry11th out of 18 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Avanos Medical.Read more about Avanos Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.63% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avanos Medical has recently increased by 5.44%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVNS. Previous Next 3.3 News and Social Media Coverage News SentimentAvanos Medical has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Avanos Medical this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for AVNS on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat Follows2 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.90% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avanos Medical's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Avanos Medical are expected to grow by 30.94% in the coming year, from $1.39 to $1.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -17.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -17.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 0.89. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Avanos Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Avanos Medical Stock (NYSE:AVNS)Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Read More AVNS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVNS Stock News HeadlinesAugust 12, 2024 | msn.comImplied Volatility Surging for Avanos (AVNS) Stock OptionsAugust 2, 2024 | markets.businessinsider.comStifel Nicolaus Remains a Hold on Avanos Medical (AVNS)September 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…August 1, 2024 | msn.comSupplementary Review: Avanos Medical (AVNS), August 1, 2024August 1, 2024 | insidermonkey.comAvanos Medical, Inc. (NYSE:AVNS) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | seekingalpha.comAvanos Medical, Inc. (AVNS) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | msn.comAvanos Medical Non-GAAP EPS of $0.34 beats by $0.05, revenue of $171.7M beats by $1.03MJuly 31, 2024 | seekingalpha.comAvanos Medical, Inc. 2024 Q2 - Results - Earnings Call PresentationSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…July 31, 2024 | prnewswire.comAvanos Medical, Inc. Announces Second Quarter 2024 ResultsJuly 25, 2024 | finance.yahoo.comAvanos Medical (NYSE:AVNS) investors are sitting on a loss of 44% if they invested five years agoJuly 24, 2024 | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial ResultsJuly 1, 2024 | prnewswire.comAvanos Medical, Inc. Appoints Indrani Franchini to Board of DirectorsMay 13, 2024 | prnewswire.comAvanos Medical, Inc. Appoints Sig Delgado as Senior Vice President, Integrated Supply ChainMay 6, 2024 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call TranscriptMay 3, 2024 | finance.yahoo.comAvanos Medical First Quarter 2024 Earnings: EPS: US$0.011 (vs US$0.17 loss in 1Q 2023)May 3, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 2, 2024 | msn.comAVNS Stock Earnings: Avanos Medical Misses EPS, Beats Revenue for Q1 2024See More Headlines Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/31/2024Today9/07/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNYSE:AVNS CUSIPN/A CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees3,771Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.33) Trailing P/E RatioN/A Forward P/E Ratio17.06 P/E GrowthN/ANet Income$-61,800,000.00 Net Margins1.13% Pretax Margin2.05% Return on Equity4.48% Return on Assets3.27% Debt Debt-to-Equity Ratio0.13 Current Ratio2.28 Quick Ratio1.49 Sales & Book Value Annual Sales$682.40 million Price / Sales1.60 Cash Flow$1.98 per share Price / Cash Flow11.97 Book Value$26.59 per share Price / Book0.89Miscellaneous Outstanding Shares45,904,000Free Float44,573,000Market Cap$1.09 billion OptionableOptionable Beta0.91 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Joseph F. Woody (Age 58)CEO & Director Comp: $2.21MMr. Michael C. Greiner (Age 51)Senior VP, CFO & Chief Transformation Officer Comp: $986.42kMs. Mojirade James (Age 57)Senior VP, General Counsel & Corporate Secretary Comp: $728.66kMr. Kerr W. Holbrook (Age 57)Senior VP & Chief Commercial Officer Comp: $747.61kMr. Sudhakar Varshney (Age 47)Senior Vice President of Global Supply Chain & Procurement Comp: $1.02MMr. John Joseph HurleyPrincipal Accounting Officer & ControllerMr. David CrawfordVP of FP&A and Investor Relations and TreasurerMs. Michelle ScharfenbergSenior VP and Chief Ethics & Compliance OfficerMr. Scott GalovanVice President of Strategy & Corporate DevelopmentJohn W. CatoVice President of Human ResourcesMore ExecutivesKey CompetitorsPROCEPT BioRoboticsNASDAQ:PRCTAxonicsNASDAQ:AXNXEnvistaNYSE:NVSTTandem Diabetes CareNASDAQ:TNDMLivaNovaNASDAQ:LIVNView All CompetitorsInsiders & InstitutionsAlgert Global LLCBought 4,646 shares on 8/16/2024Ownership: 0.145%AQR Capital Management LLCBought 25,467 shares on 8/15/2024Ownership: 0.320%Mackenzie Financial CorpBought 8,775 shares on 8/15/2024Ownership: 0.056%The Manufacturers Life Insurance Company Bought 590 shares on 8/15/2024Ownership: 0.037%Caxton Associates LPBought 2,034 shares on 8/15/2024Ownership: 0.037%View All Insider TransactionsView All Institutional Transactions AVNS Stock Analysis - Frequently Asked Questions How have AVNS shares performed this year? Avanos Medical's stock was trading at $22.43 at the start of the year. Since then, AVNS shares have increased by 5.8% and is now trading at $23.72. View the best growth stocks for 2024 here. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) posted its earnings results on Wednesday, July, 31st. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.05. The firm's revenue was up 1.4% compared to the same quarter last year. What is Joseph F. Woody's approval rating as Avanos Medical's CEO? 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Who are Avanos Medical's major shareholders? Avanos Medical's top institutional investors include Dimensional Fund Advisors LP (5.62%), Westwood Holdings Group Inc. (4.54%), William Blair Investment Management LLC (3.09%) and Paradice Investment Management LLC (2.93%). Insiders that own company stock include Michael Greiner, Julie Ann Shimer and Patrick J Oleary. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ) and RTX (RTX). This page (NYSE:AVNS) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
